-
1 Comment
AstraZeneca Pharma India Limited is currently in a long term downtrend where the price is trading 8.4% below its 200 day moving average.
From a valuation standpoint, the stock is 121.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.6.
AstraZeneca Pharma India Limited's total revenue sank by 10.5% to $2B since the same quarter in the previous year.
Its net income has dropped by 21.2% to $211M since the same quarter in the previous year.
Finally, its free cash flow fell by 98.0% to $13M since the same quarter in the previous year.
Based on the above factors, AstraZeneca Pharma India Limited gets an overall score of 0/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | NSE |
| CurrencyCode | INR |
| ISIN | INE203A01020 |
| Dividend Yield | 0.3% |
|---|---|
| Beta | 0.28 |
| Market Cap | 225B |
| PE Ratio | 230.65 |
| Target Price | None |
AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease, renal, and metabolism medicines under the CRESTOR, Forxiga, BRILINTA, Xigduo, and Seloken XL brand names; oncology medicines under the TAGRISSO, CALQUENCE, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ASTRAZEN.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
